|
US6071957A
(en)
|
1996-11-27 |
2000-06-06 |
The University Of Tennessee Research Corporation |
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
|
|
US7759520B2
(en)
|
1996-11-27 |
2010-07-20 |
University Of Tennessee Research Foundation |
Synthesis of selective androgen receptor modulators
|
|
US6995284B2
(en)
|
2000-08-24 |
2006-02-07 |
The University Of Tennessee Research Foundation |
Synthesis of selective androgen receptor modulators
|
|
US8445534B2
(en)
|
2000-08-24 |
2013-05-21 |
University Of Tennessee Research Foundation |
Treating androgen decline in aging male (ADAM)-associated conditions with SARMs
|
|
US6998500B2
(en)
|
2000-08-24 |
2006-02-14 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
|
US8008348B2
(en)
|
2001-12-06 |
2011-08-30 |
University Of Tennessee Research Foundation |
Treating muscle wasting with selective androgen receptor modulators
|
|
US6838484B2
(en)
|
2000-08-24 |
2005-01-04 |
University Of Tennessee Research Foundation |
Formulations comprising selective androgen receptor modulators
|
|
US7622503B2
(en)
|
2000-08-24 |
2009-11-24 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
|
US7026500B2
(en)
|
2000-08-24 |
2006-04-11 |
University Of Tennessee Research Foundation |
Halogenated selective androgen receptor modulators and methods of use thereof
|
|
US6737550B2
(en)
*
|
2001-06-13 |
2004-05-18 |
Biogal Gryogyszergyar Rt. |
Process for preparing rac-bicalutamide and its intermediates
|
|
US8853266B2
(en)
|
2001-12-06 |
2014-10-07 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators for treating diabetes
|
|
PT1463497E
(pt)
|
2001-12-06 |
2011-12-20 |
Gtx Inc |
Tratamento do desgaste muscular com moduladores selectivos do receptor de androgénios
|
|
US6740770B2
(en)
|
2001-12-13 |
2004-05-25 |
Sumika Fine Chemicals Co., Ltd. |
Crystal of bicalutamide and production method thereof
|
|
CA2689080C
(en)
|
2002-02-07 |
2011-07-05 |
University Of Tennessee Research Foundation |
Treating benign prostate hyperplasia with sarms
|
|
JP5113979B2
(ja)
|
2002-02-28 |
2013-01-09 |
ユニバーシティ オブ テネシー リサーチ ファウンデーション |
複数置換の選択的アンドロゲンレセプタ修飾因子及びその使用方法
|
|
US7772433B2
(en)
|
2002-02-28 |
2010-08-10 |
University Of Tennessee Research Foundation |
SARMS and method of use thereof
|
|
WO2003074450A2
(en)
|
2002-02-28 |
2003-09-12 |
The University Of Tennessee Research Corporation |
Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
|
|
US7803970B2
(en)
|
2002-02-28 |
2010-09-28 |
University Of Tennessee Research Foundation |
Multi-substitued selective androgen receptor modulators and methods of use thereof
|
|
DE10222104A1
(de)
|
2002-05-17 |
2003-12-04 |
Helm Ag |
Verfahren zur Herstellung von N-(4'-Cyano-3'-trifluormethyl)-3-(4"-fluorphenylsulfonyl)-2-hydroxy-2-methylpropionamid
|
|
US7741371B2
(en)
|
2002-06-17 |
2010-06-22 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
|
AU2003241583B2
(en)
|
2002-06-17 |
2009-05-21 |
University Of Tennessee Research Foundation |
N-bridged selective androgen receptor modulators and methods of use thereof
|
|
DE50213170D1
(de)
*
|
2002-09-04 |
2009-02-12 |
Fraunhofer Ges Forschung |
Verwendung eines Mittel zur Therapie der Herzhypertrophie
|
|
US20040063782A1
(en)
*
|
2002-09-27 |
2004-04-01 |
Westheim Raymond J.H. |
Bicalutamide forms
|
|
US6818766B2
(en)
|
2002-10-02 |
2004-11-16 |
Synthon Bv |
Process for making bicalutamide and intermediates thereof
|
|
EP1562594A4
(en)
|
2002-10-15 |
2008-12-17 |
Univ Tennessee Res Foundation |
SELECTIVE ANDROGEN RECEPTOR MODULATORS WITH METHYLENE BRIDGES AND METHOD OF USE THEREOF
|
|
US8309603B2
(en)
|
2004-06-07 |
2012-11-13 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
|
JP4322621B2
(ja)
|
2003-10-16 |
2009-09-02 |
住友化学株式会社 |
4’−シアノ−3−[(4−フルオロフェニル)スルホニル]−2−ヒドロキシ−2−メチル−3’−トリフルオロメチルプロピオンアニリドの製造方法
|
|
AU2004305061A1
(en)
|
2003-12-16 |
2005-07-07 |
Gtx, Inc. |
Prodrugs of selective androgen receptor modulators and methods of use thereof
|
|
US9889110B2
(en)
|
2004-06-07 |
2018-02-13 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulator for treating hormone-related conditions
|
|
US9884038B2
(en)
|
2004-06-07 |
2018-02-06 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulator and methods of use thereof
|
|
WO2008013791A2
(en)
*
|
2006-07-24 |
2008-01-31 |
University Of Delaware |
Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal
|
|
AU2007287070C1
(en)
|
2006-08-24 |
2013-02-14 |
University Of Tennessee Research Foundation |
Substituted acylanilides and methods of use thereof
|
|
US9730908B2
(en)
|
2006-08-24 |
2017-08-15 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
|
US9844528B2
(en)
|
2006-08-24 |
2017-12-19 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
|
US10010521B2
(en)
|
2006-08-24 |
2018-07-03 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
|
US7968603B2
(en)
|
2007-09-11 |
2011-06-28 |
University Of Tennessee Research Foundation |
Solid forms of selective androgen receptor modulators
|
|
WO2010116342A2
(en)
*
|
2009-04-10 |
2010-10-14 |
Consiglio Nazionale Delle Ricerche |
Non-steroidal compounds for androgen receptor modulation
|
|
ITBO20090236A1
(it)
*
|
2009-04-10 |
2010-10-11 |
Consiglio Nazionale Ricerche |
Procedimento per la sintesi di composti per il trattamento del tumore alla prostata
|
|
WO2011008543A2
(en)
*
|
2009-06-29 |
2011-01-20 |
University Of Delaware |
Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal
|
|
CN103539710A
(zh)
*
|
2012-07-02 |
2014-01-29 |
国药一心制药有限公司 |
一种(r)-比卡鲁胺的合成方法
|
|
US9969683B2
(en)
|
2012-07-13 |
2018-05-15 |
Gtx, Inc. |
Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
|
|
EP3733170A1
(en)
|
2012-07-13 |
2020-11-04 |
Oncternal Therapeutics, Inc. |
A method of treating androgen receptor (ar) -positive breast cancers with selective androgen receptor modulator (sarms)
|
|
US10987334B2
(en)
|
2012-07-13 |
2021-04-27 |
University Of Tennessee Research Foundation |
Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
|
|
US10314807B2
(en)
|
2012-07-13 |
2019-06-11 |
Gtx, Inc. |
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
|
|
US9744149B2
(en)
|
2012-07-13 |
2017-08-29 |
Gtx, Inc. |
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
|
|
US9622992B2
(en)
|
2012-07-13 |
2017-04-18 |
Gtx, Inc. |
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
|
|
US10258596B2
(en)
|
2012-07-13 |
2019-04-16 |
Gtx, Inc. |
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
|
|
US12685719B2
(en)
|
2012-07-13 |
2026-07-21 |
University Of Tennessee Research Foundation |
Treatment of breast cancer with selective androgen receptor modulators and cyclin-dependent kinase 4/6 inhibitors
|